Science & Technology
Tue, January 17, 2012Mon, January 16, 2012Sun, January 15, 2012Sat, January 14, 2012Fri, January 13, 2012Thu, January 12, 2012Wed, January 11, 2012Tue, January 10, 2012Cepheid Schedules 2011 Fourth Quarter and Full Year Financial Results Announcement and Webcast
//science-technology.news-articles.net/content/2 .. -financial-results-announcement-and-webcast.html
Published in Science and Technology on Wednesday, January 11th 2012 at 13:11 GMT by Market Wire🞛 This publication is a summary or evaluation of another publication
Cepheid Schedules 2011 Fourth Quarter and Full Year Financial Results Announcement and... -- SUNNYVALE, Calif., Jan. 11, 2012 /PRNewswire/ --
Cepheid Schedules 2011 Fourth Quarter and Full Year Financial Results Announcement and Webcast
SUNNYVALE, Calif., Jan. 11, 2012 /PRNewswire/ -- Cepheid (Nasdaq: [ CPHD ]) today announced that it will report financial results for its 2011 fourth quarter and full year ended December 31, 2011, on Thursday, January 26, 2012, after the close of the market.
The Company will host a management presentation at 2 p.m. Pacific Time on Thursday, January 26, 2012, to discuss the results. To access the live webcast, please visit Cepheid's website at [ www.cepheid.com/investors ] at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software. A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.
Interested participants and investors may also listen to the live teleconference call by dialing (866) 713-8395 or (617) 597-5309, and entering participant code 42214013. A replay will be available for seven days beginning at 4 p.m. Pacific Time. Access numbers for this replay are (888) 286-8010 or (617) 801-6888, with passcode 57636855.
About Cepheid
Based in Sunnyvale, Calif., Cepheid is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit [ http://www.cepheid.com ].
CONTACTS: | ||||
For Media Inquiries: | For Investor Inquiries: |
| ||
Jared Tipton Cepheid Corporate Communications Tel: (408) 400 8377 |
Jacquie Ross Cepheid Investor Relations Tel: (408) 400 8329 |
| ||
| ||||
SOURCE Cepheid
[ Back to top ] RELATED LINKS
[ http://www.cepheid.com ]
